THC Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Tenet Healthcare Corp (THC) is a good buy for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. The stock shows strong financial performance, positive analyst sentiment, and bullish technical indicators. While insider selling is a concern, the overall positive catalysts outweigh the negatives.
The stock is in a bullish trend with MACD above 0 and positively contracting, RSI at 79.625 in the neutral zone, and moving averages indicating upward momentum (SMA_5 > SMA_20 > SMA_200). Key resistance levels are at R1: 239.229 and R2: 243.248, while support levels are at S1: 226.218 and S2: 222.199.
Hedge funds are significantly increasing their positions, with a 337.36% increase in buying over the last quarter.
Analysts have consistently raised price targets, with the highest target at $288, indicating strong growth potential.
Financials show robust growth in revenue (8.95% YoY), net income (16.67% YoY), and EPS (27.88% YoY).
Insider selling has increased by 1492.05% over the last month, which could indicate caution from company insiders.
Gross margin dropped slightly by -0.40% YoY, though this is not a major concern given overall financial growth.
In Q4 2025, Tenet Healthcare reported an 8.95% YoY increase in revenue to $5.53 billion, a 16.67% YoY increase in net income to $371 million, and a 27.88% YoY increase in EPS to 4.22. However, gross margin slightly declined to 77.55%, down -0.40% YoY.
Analysts are overwhelmingly positive on THC, with multiple firms raising their price targets and maintaining Buy or Overweight ratings. The highest price target is $288, and analysts highlight strong fundamentals, better-than-expected Q4 results, and alignment with key market narratives as reasons for optimism.
